Words of wisdom. Re: Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer.
Beuzeboc
P
P
Institut Curie, 26 rue d'Ulm, Paris 75005, France. philippe.beuzeboc@curie.net